Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 200 Applications Received to Align Indications with Original Products
October 2, 2006
- Reducing Average Length of Hospital Stay Essential: Vice Minister
October 2, 2006
- Taiyo Pharm. Completes Seamless Production Line for Prefilled Syringes
October 2, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 2, 2006
- Wholesalers Must Offer Well-Grounded Prices: Korosho Hearing
October 2, 2006
- Novartis, Daiichi Sankyo to Terminate Agreement for Lamisil AT, Nicotinel TTS
October 2, 2006
- Inter-ministerial Efforts Accelerated to Promote Life Science
October 2, 2006
- SSP to Launch CHOLESTEGUARD to Fight High Cholesterol
October 2, 2006
- Barcode Labering Requirements Annouced
October 2, 2006
- Industry Seeks to Bring About Gov't-Industry Dialogue: JPMA Policy Seminar
October 2, 2006
- Pneumococcal Vaccination in the Elderly Needs Government Support
September 25, 2006
- Kowa Pharmaceutical Aims for Sales of \74.8 Bil. in FY2007
September 25, 2006
- R&D NEWS IN BRIEF
September 25, 2006
- Once-weekly Osteoporosis Drug Both Effective and Convenient
September 25, 2006
- Dr Bale Discusses Current Top Priorities at IFPMA
September 25, 2006
- Korosho to Promote Domestic Vaccine Development, Blood Donation
September 25, 2006
- Aging, Vitamin C Deficiency Contribute to COPD
September 25, 2006
- Global Partnerships Essential in BT Industry: Dr Mimura
September 25, 2006
- Online Processing of Medical Bills to Expand in April 2007
September 25, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 25, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…